SkinBioTherapeutics (LON:SBTX) Trading 12.7% Higher – Still a Buy?

SkinBioTherapeutics plc (LON:SBTX)’s share price traded up 12.7% on Monday . The company traded as high as GBX 18 ($0.23) and last traded at GBX 17.85 ($0.23). 2,720,522 shares changed hands during mid-day trading, an increase of 178% from the average session volume of 979,359 shares. The stock had previously closed at GBX 15.84 ($0.20).

SkinBioTherapeutics Stock Performance

The business’s fifty day moving average price is GBX 13.93 and its two-hundred day moving average price is GBX 11.95. The company has a debt-to-equity ratio of 2.66, a quick ratio of 10.01 and a current ratio of 6.57. The stock has a market capitalization of £40.13 million, a P/E ratio of -800.00 and a beta of 2.01.

SkinBioTherapeutics Company Profile

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.